Solthis Solidarité Thérapeutique et Initiatives pour la Santé

Do not wait for the crisis to act

Donate now

Mobilization against free trade agreements (ACTA) between European Union and India

July 2012

16 July 2012 |  Position statement

ADVOCACYHEALTH PRODUCTS AND PHARMACEUTICAL SYSTEM

As one of the most important generic drug producers, India became the main “pharmacy” of developping countries. Generics represent 80% of treatments purchased by international donors in 115 low and middle income countries. Since 2007, European Union and India negociate bilateral free trade agreements which reinforce intellectual property rights and undermine access to cheap health products, such as vaccines or essential medicines.
Solthis and several associations mobilized in 2011 demanded to the European Union and India to remove measures strengthening intellectual property rights.

 

On 4th july 2012, the European Parlamentarians vote against the Anti-Counterfeiting Trade Agreement (ACTA) with a very large majority : 478 against, 165 abstentions and only 39 in favour.

Twitter

Facebook

Events

No event has been found

Fri

19

Nov

From 19 November 2021 to 21 November 2021

AFRAMED 2021

AFRAMED 2021

Hammamet, Tunisie

HEPATITISHIV / AIDS


Mon

06

Dec

From 6 December 2021 to 11 December 2021

Solthis at ICASA 2021

Solthis at ICASA 2021

HIV / AIDS

Tout afficher

© Solthis 2021 - All rights reserved | Legal notice | Personal data | Cookie Management | Sitemap